| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |